Show items per page
Elements: 267
Page 1 on 6
 TitleAuthors / EditorsDate
add to browser selection
Who will treat inflammatory skin diseases in the year 2020? Boehncke, Wolf-Henning 2018
add to browser selection
Vertraglichkeit des selektiven Cyclooxygenase-2-Inhibitors Rofecoxib bei Intoleranz gegenuber nicht-steroidalen Antiphlogistika Zollner, Thomas Matthias; Ahlbach, Sandra; Kaufmann, Roland; Boehncke, Wolf-Henning 2001
add to browser selection
Urticaria associated with a small cell carcinoma of the lung Greiner, Daniela; Schofer, Helmut; Boehncke, Wolf-Henning 2002
add to browser selection
Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment Boehncke, Wolf-Henning; Brembilla, Nicolo Costantino 2017
add to browser selection
Type-IV hypersensitivity to topical estradiol in a patient tolerant to it orally Boehncke, Wolf-Henning; Gall, H. 1996
add to browser selection
Type I and type II psoriasis show a similar usage of T-cell receptor variable regions Schmitt-Egenolf, M.; Boehncke, Wolf-Henning; Christophers, Enno; Stander, M.; Sterry, Wolfram 1991
add to browser selection
Treatment recommendations for psoriatic arthritis Ritchlin, C. T.; Kavanaugh, A.; Gladman, D. D.; Mease, P. J.; ... Taylor, W. J. 2009
add to browser selection
Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases Thaci, Diamant; Patzold, S.; Kaufmann, Roland; Boehncke, Wolf-Henning 2005
add to browser selection
Treatment of psoriasis by topical photodynamic therapy with polychromatic light Boehncke, Wolf-Henning; Sterry, Wolfram; Kaufmann, Roland 1994
add to browser selection
Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil Grundmann-Kollmann, Marcella; Mooser, G.; Schraeder, P.; Zollner, Thomas Matthias; ... Peter, R. U. 2000
add to browser selection
Toleranz von Coxiben bei Intoleranz gegenuber nicht-steroidalen Antirheumatika (NSAR) Boehncke, Sandra; Boehncke, Wolf-Henning 2005
add to browser selection
Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids Boehncke, Wolf-Henning; Weber, L.; Gall, H. 1996
add to browser selection
Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature Weberschock, Tobias Bernd Bernd; Muller, Sylke-Monina; Boehncke, Sandra; Boehncke, Wolf-Henning 2007
add to browser selection
Tolerance to a group C corticosteroid systemically in a patient with delayed-type hypersensitivity to group A systemic corticosteroids Zedlitz, Sven; Ahlbach, Sandra; Kaufmann, Roland; Boehncke, Wolf-Henning 2002
add to browser selection
Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin Schindewolf, Marc; Ludwig, Ralf J.; Wolter, Manfred; Himsel, A.; ... Lindhoff-Last, Edelgard 2008
add to browser selection
Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans Ludwig, Ralf J.; Beier, Christian; Lindhoff-Last, Edelgard; Kaufmann, Roland; Boehncke, Wolf-Henning 2003
add to browser selection
Therapy of psoriasis in childhood and adolescence - a German expert consensus Sticherling, Michael; Augustin, Matthias; Boehncke, Wolf-Henning; Christophers, Enno; ... Mrowietz, Ulrich 2011
add to browser selection
Therapieempfehlungen fur Psoriasisarthritis Boehncke, Wolf-Henning 2009
add to browser selection
Therapie der Psoriasis-Arthritis und der Psoriasis vulgaris mit Infliximab Mrowietz, Ulrich; Barth, Joachim; Boehncke, Wolf-Henning; Reich, Kristian; ... Wozel, Gottfried 2006
add to browser selection
Therapie der Psoriasis vulgaris und Psoriasis--Arthritis mit Etanercept Mrowietz, Ulrich; Barth, Joachim; Boehncke, Wolf-Henning; Rosenbach, Thomas; Wozel, Gottfried 2005
add to browser selection
Therapie der Psoriasis vulgaris mit Efalizumab Mrowietz, Ulrich; Barth, Joachim; Boehncke, Wolf-Henning; Reich, Kristian; ... Wozel, Gottfried 2006
add to browser selection
The Western blot is a highly sensitive and efficient technique in diagnosing allergy to wasp venom Zollner, Thomas Matthias; Spengler, K.; Podda, Maurizio; Ergezinger, K.; ... Boehncke, Wolf-Henning 2001
add to browser selection
The T-cell receptor Vbeta repertoire of nickel-specific T cells Zollner, Thomas Matthias; Neubert, C.; Wettstein, A.; Boehncke, Wolf-Henning; ... Sterry, Wolfram 1998
add to browser selection
The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytes Zollner, Thomas Matthias; Munk, M. E.; Keller, T.; Nuber, V.; ... Kaufmann, Roland 1996
add to browser selection
The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria Boehncke, Wolf-Henning; Ludwig, Ralf J.; Zollner, Thomas Matthias; Ochsendorf, Falk Rudiger; ... Gibbs, B. F. 2003
add to browser selection
The SCID-hu xenogeneic transplantation model: complex but telling Boehncke, Wolf-Henning 1999
add to browser selection
The SCID-hu xenogeneic transplantation model allows screening of anti-psoriatic drugs Boehncke, Wolf-Henning; Kock, M.; Hardt-Weinelt, K.; Wolter, Manfred; Kaufmann, Roland 1999
add to browser selection
The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis Girolomoni, G; Strohal, R; Puig, L; Bachelez, H; ... Prinz, J C 2017
add to browser selection
The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review Weberschock, Tobias Bernd; Meister, Anna Christina; Bohrt, Kevin; Schmitt, Jochen; ... Ludwig, Ralf J. 2011
add to browser selection
The psoriasis xenograft SCID mouse model : a tool in translational research Boehncke, Wolf-Henning 2012
add to browser selection
The psoriasis SCID mouse model: a tool for drug discovery? Boehncke, Wolf-Henning 2005
add to browser selection
The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders Schon, Michael P.; Zollner, Thomas Matthias; Boehncke, Wolf-Henning 2003
add to browser selection
The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meeting Gottlieb, Alice B; Armstrong, April W; Christensen, Robin; Garg, Amit; ... Abernethy, April 2014
add to browser selection
The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity Fritzsche, Juliane; Alban, Susanne; Ludwig, Ralf J.; Rubant, Simone A.; ... Bendas, Gerd 2006
add to browser selection
The influence of heparin's molecular weight and the incidence of delayed type hypersensitivity reactions revisited; in response to Grims et al., Br J Dermatol 2007; 157:514-17 Ludwig, Ralf J.; Schindewolf, Marc; Lindhoff-Last, Edelgard; Boehncke, Wolf-Henning 2008
add to browser selection
The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition Boehncke, Wolf-Henning; Takeshita, T.; Pendleton, C. D.; Houghten, R. A.; ... Germain, R. N. 1993
add to browser selection
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond Brembilla, Nicolo; Senra, Luisa; Boehncke, Wolf-Henning 2018
add to browser selection
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists Boehncke, Wolf-Henning; Anliker, Mark David; Conrad, Curdin; Dudler, Jean; ... Gabay, Cem 2015
add to browser selection
The alpha-defensins HNP-1 and HNP-2 are dominant self-peptides presented by HLA class-II molecules in lesional psoriatic skin Boehncke, Wolf-Henning 2004
add to browser selection
The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo Ludwig, Ralf J.; Alban, Susanne; Bistrian, Roxana; Boehncke, Wolf-Henning; ... Gille, Jens 2006
add to browser selection
The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity Boehncke, Wolf-Henning; Boehncke, Sandra; Tobin, Anne-Marie; Kirby, Brian 2011
add to browser selection
Targeting selectin functions in the therapy of psoriasis Schon, Michael P.; Drewniok, Claudia; Boehncke, Wolf-Henning 2004
add to browser selection
T-cell-receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associated V beta regions Boehncke, Wolf-Henning; Dressel, Daniela; Manfras, B.; Zollner, Thomas Matthias; ... Sterry, Wolfram 1995
add to browser selection
T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin Potoczna, N.; Boehncke, Wolf-Henning; Nestle, F. O.; Kuenzlen, C.; ... Dummer, R. 1996
add to browser selection
Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial Boehncke, Sandra; Fichtlscherer, Stephan; Salgo, Rebekka; Garbaraviciene, Jurate; ... Boehncke, Wolf-Henning 2011
add to browser selection
Systemic photodynamic therapy is a safe and effective treatment for psoriasis Boehncke, Wolf-Henning; Elshorst-Schmidt, T.; Kaufmann, Roland 2000
add to browser selection
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences Boehncke, Wolf-Henning 2018
add to browser selection
Systemic antipsoriatic therapy may reverse endothelial dysfunction Boehncke, Wolf-Henning; Boehncke, Sandra 2011
add to browser selection
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris Kolios, Antonios G.A.; Yawalkar, Nikhil; Anliker, Mark; Boehncke, Wolf-Henning; ... Navarini, Alexander A. 2016
add to browser selection
Surinfection de plaie chronique par Pseudomonas aeruginosa Tzika, Evangelia; Ferrara, Donato; Boehncke, Wolf-Henning; Toutous Trellu, Laurence Marie; Barouti, Neda 2015
<< previous | 1 | 2 | 3 | 4 | 5 | 6 |